Pursuant to Regulation 30 and Regulation 33 of SEBI (LODR) Regulations, 2015 this is to inform you that the Board of Directors at its meeting held on Thursday, 12th February, 2026 has inter alia considered and approved the following:1. The Un-audited Financial results Standalone and Consolidated as per indian accounting Standards (IND AS) along with the Limited review Report (s) issued by the Statutory Auditor for the Quarter and Nine Months ended 31st December, 2025.The meeting of the Board of Directors of the Company commenced ot 2:30 P.M. and concluded at 3:00 P.M
Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31ST December 2025
View original source (BSE India)Vivanza Biosciences Ltd. on 6ix
Earlier from Vivanza Biosciences
- Vivanza Biosciences Ltd. Press Release Feb 05 2026
- Board Meeting Intimation for Consideration Of Financial Result For The Quarter And Nine Months Ended 31St December, 2025
- Vivanza Biosciences Ltd. Press Release Jan 02 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Vivanza Biosciences Ltd. Press Release Dec 26 2025
Later from Vivanza Biosciences
- Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Vivanza Biosciences Ltd. Press Release Feb 12 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Vivanza Biosciences Ltd. Press Release Feb 13 2026
- Closure of Trading Window
Follow Vivanza Biosciences into a list and get an email when it puts out news.
Follow Vivanza Biosciences